Cuestionario sorpresa: ¿cuánto sabe sobre la centralidad en el paciente?

¿Qué problemas presentan los pacientes como obstáculos para no participar en un estudio clínico? ¿Cuán lejos están dispuestos a viajar para participar en un estudio y cuán dispuestos están a participar sabiendo que su médico está al tanto de dicho estudio?Cuestionario sobre centralidad en el paciente

Hicimos estas preguntas y otras más a grupos de 135.000 personas que aceptaron ingresar en la base de datos de LabCorp para recibir más información sobre los estudios clínicos de Covance. Más de 2.500 respondieron a nuestra encuesta, y sus respuestas permitieron a nuestro equipo tener un conocimiento profundo inigualable para comprender mejor la mentalidad de los pacientes, y diseñar estrategias de reclutamiento más efectivas.

Luego, para ver si nuestros colegas en la industria del desarrollo farmacológico podían sacar una conclusión a partir de la suma de respuestas de nuestros participantes a esta encuesta, elaboramos un breve cuestionario sorpresa. Los asistentes que visitaron nuestro stand en la reunión anual 2017 de la Asociación sobre Información Farmacológica (DIA) tuvieron la oportunidad de completar el cuestionario y ver cuán bien lo habían contestado.

While the survey sent to people who opted in through LabCorp covered a wide range of topics, we focused on five questions in our quiz for industry partners. With a multiple-choice format, they were asked:

  1. What is the MOST significant issue keeping patients from participating in clinical studies?
  2. On average, what is the MAXIMUM distance a potential participant would be willing to travel in order to participate in a study?
  3. What percentage of potential study participants proactively researched and/or discussed a clinical study with a professional, but did not participate?
  4. What percentage of potential study participants are MUCH MORE WILLING to participate knowing that their physician is aware of the study?
  5. What percentage of potential study participants are VERY WILLING to wear a mobile device (Fitbit®, watch/wearable) outside of standard study visits to support the study experience?

So, how well did our industry peers do? Drum roll please … Of the nearly 100 booth visitors that took our survey, most participants answered one or two correctly out of the five questions. For me, it was not really about the score itself but rather the underlying message that was revealed: our industry needs to elevate the importance of patient centricity. Are we truly embedding the viewpoint of the patient as we design our protocols? Are we considering how we are going to get our desired study endpoints and what we can do for the patient to make the overall journey easier?

As a follow-up to the quiz, there was significant discussion about how to gain a better understanding of patient views related to clinical study participation and the downstream impact for everyone involved. I heard one of my colleagues tell the story of how they supported a study partner by using patient insights to help rally a group of investigators that was otherwise extremely hesitant to sign up for a rare disease trial. While that study is still in progress, it provided firsthand evidence of how these data can have a direct influence on optimizing a study.

I think that while we would all agree that putting the patient at the center of what we do can be a daunting and complex undertaking, it is no longer a "nice to have" feature, but a must for the industry as a whole. Our quickly changing and ever-shrinking world has provided an opportunity for pharmaceutical companies to put the patient at the center of all drug development efforts and I, for one, am excited to see Covance be a driving force in this effort.

Would you like test out your patient centricity IQ? Take the same five-question, multiple-choice quiz that was given to attendees at DIA 2017 and see how well you align with the thinking of potential study participants.